National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

tanezumab
A humanized monoclonal antibody directed against nerve growth factor (NGF), a modulator of nociceptor function, with potential analgesic activity. Tanezumab binds to NGF and prevents NGF binding to its high affinity, membrane-bound, catalytic receptor tropomyosin-related kinase A (TrkA), which is present on sympathetic and sensory neurons; reduced stimulation of TrkA by NGF inhibits the pain-transmission activities of these neurons. NGF, a neurotrophin, is critical to the growth and maintenance of sympathetic and sensory neurons. In addition, NGF may induce mast cells to release inflammatory proteins and may induce the upregulation of substance P and other pain-related peptides in sympathetic and sensory neurons. Upon neurotrophin binding, TrkA phosphorylates itself and members of the MAPK pathway, mediating the multiple neuronal effects of NGF. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:anti-NGF monoclonal antibody RN624
Code name:RN624
Chemical structure names:
  • Immunoglobulin G2, anti (human nerve growth factor) humanized mouse monoclonal N624 [Lys71,Ser330,Ser331]gamma 2 heavy chain (135-214')-disulfide with kappa light chain (223-23'':224-224'':227-227'':230-230'')-tetrakisdisulfide dimer
  • immunoglobulin G2, anti (human nerve growth factor)(human mouse monoclonal N624 heavy chain), disulfide with human mouse monoclonal RN624 light chain, dimer



Previous:tamibarotene, tamoxifen citrate, tamsulosin hydrochloride, tandutinib, tanespimycin
Next:tanomastat, tapentadol hydrochloride ER, Tarabine PFS, Tarceva, Targocid

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov